What stage does New Science Ventures invest at?

New Science Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is New Science Ventures's typical check size?

New Science Ventures typically writes checks of $2M – $8M.

Where is New Science Ventures located?

New Science Ventures is headquartered in Greenwich, US.

Does New Science Ventures lead rounds?

Yes, New Science Ventures leads investment rounds.

New Science Ventures

Venture capital

Greenwich · Seed–Late Stage · 7 people tracked

Also known as NSV · NSV MANAGEMENT LLC

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

New Science Ventures invests in both early- and late-stage companies pursuing breakthrough, novel scientific approaches to address significant unmet needs in the life sciences and information technology sectors. The firm targets areas with strong decades-long tailwinds where its team has direct experience and can leverage extensive external networks to help create value. Its portfolio spans biotech and therapeutics, semiconductors, advanced materials such as graphene, space and satellite data, telecom/5G, and data platforms, reflecting a science-driven approach across the US and Europe.

Invests inAI & Machine Learning Biotech Data & Infrastructure Deep Tech Digital Health Enterprise Software Healthtech Medical Devices Mobility & Transportation New Materials Semiconductors Space TechEuropeGreenwichNorth AmericaUnited KingdomUnited States

Source: firm website, verified Aug 11, 2026.

Stage

Seed–Late Stage

Check

$2M – $8M

Greenwich, Connecticut, US

Leads rounds

Leads

Instruments

Equity

Founded

2004

Last 12 months

1 investment

AUM

$900M

VC funds

Tracked investments

Team · 7 people

from the firm's website & public directories

Somu Subramaniam· Co-founder and Managing Partner

Somu Subramaniam co-founded New Science Ventures, where he is Managing Partner. Before starting the firm, he was a director at McKinsey & Company, advising companies across pharmaceuticals, medical devices, biotechnology, photonics, software, and semiconductors, and led parts of its Strategy, Technology, and Healthcare practices while serving on its Investment Committee. He holds a B.Tech. from the Indian Institute of Technology and an M.B.A. from Harvard Business School.

s•••@newscienceventures.comreveal

Tom Lavin· Co-founder and Partner

Tom Lavin is a co-founder and Partner of New Science Ventures. Before NSV, he spent over 30 years in finance and investment banking, including roles as head of real estate investment banking at First Boston and Smith Barney and head of commercial mortgage lending at MetLife, with experience in private and public equity and debt transactions, M&A, and financial restructurings. He holds an A.B. in Government from Wesleyan University and an M.B.A. from Harvard Business School.

t•••@newscienceventures.comreveal

Andrew Abrams· Partner· London

Andrew Abrams is a Partner at New Science Ventures, which he joined as an Associate in September 2016 before becoming Partner in July 2020. He previously worked as an Associate in J.P. Morgan's healthcare investment banking practice in London, advising biotechnology, pharmaceutical, medical device, diagnostic and service clients on M&A and equity transactions across Europe and the U.S. He holds B.A., M.A. and M.Sci. degrees in Natural Sciences and Biochemistry from the University of Cambridge and an M.B.A. from Harvard Business School.

a•••@newscienceventures.comreveal

Jean-Pierre Bizet· Partner and Senior Advisor

Jean-Pierre Bizet joined New Science Ventures as a Partner and Senior Advisor in February 2015 and serves as a non-executive director on several company boards. He is a professor of strategy at Université Libre de Bruxelles and previously served as CEO of D'Ieteren and CEO of GIB Group, after working as a Director at McKinsey & Company in Paris. He holds a PhD in Applied Economics from the University of Brussels, an MBA from Harvard Business School, and an MS from Solvay Brussels School of Economics & Management.

b•••@newscienceventures.comreveal

Brenda Marex· Chief Financial Officer

Brenda Marex is Chief Financial Officer at New Science Ventures, which she joined in October 2010. She previously worked as a fund controller at Cerberus Capital and as a Controller and Vice President at Citigroup Alternative Investments, and began her career at the accounting firm Eisner. She holds a B.A. in Accounting and Information Systems from Queens College and is a Certified Public Accountant in New York.

b•••@newscienceventures.comreveal

Matt Crotty· Controller

Matt Crotty is Controller at New Science Ventures, which he joined in October 2025. He previously served as Director of the Center of Excellence at SteelBridge Consulting and as Senior Director of Fund Services North America at TMF Group, having earlier worked as a Director at fund administrator Venture Back Office and beginning his career as an auditor at Ernst & Young. He holds a Master's in Accounting and a B.S. in Business Administration from the University of North Carolina at Chapel Hill and is a licensed CPA in North Carolina.

Raju Mohan· Partner and Senior Advisor

r•••@newscienceventures.comreveal

What they invest in

from 8 of 34 portfolio companies

Hardware ×3Semiconductors ×3AI & Machine Learning ×2Biotech ×2Deep Tech ×2Space Tech ×2Cloud Computing ×1Data & Infrastructure ×1

HQs:United States×10

Investments · 34 tracked

founders shown can be your intro path

By year:2026 · 1 2024 · 1 2023 · 2 2022 · 15 dated

ABL Space Systemsablspacesystems.com𝕏Dec 2023SEC filingmedium confidence

ABL Space Systems develops small satellite launch vehicles, including the RS1 rocket and GS0 containerized launch system, enabling orbital launches from various ground locations.

HardwareSpace TechEl Segundo, US

Harrison O'Hanley(Chief Executive Officer)Kevin Sagis(Chief Product Officer and Enterprise Chief Engineer)Ronald O'Hanley(Director)Daniel Piemont(Chief Financial Officer, President and Secretary)

BoardEthan Batraski(Director)

Board seatSomu Subramaniam· per SEC Form D · $100M raise · filed Dec 2023

Ferricferric.cominDec 2024

Ferric develops power management technology based on magnetic materials and semiconductors, holding patents in integrated voltage regulation.

Deep TechHardwareSemiconductorsNew York, US

Noah Sturcken(Executive Officer, Director)Kenneth Shepard(Director)

BoardYi Chen(Director)Alex Kalnitsky(Director)Lawrence Pileggi(Director)

Board seatSomu Subramaniam· per SEC Form D

Vascular TherapiesMar 2022SEC filingmedium confidence

BiotechCresskill, US

Allan Tessler(Director)Michael Bamberger(Director)Gerald Dorros(Director)Kiyoshi Takesue(Director)Sriram Iyer(Executive Officer, Director)Robert Croce(Director)

Board seatSomu Subramaniam· per SEC Form D · $25.2M raise · filed Mar 2022

Achronixachronix.comin 𝕏

Angel Veteran-Led PlanetiQplanetiq.comin

Antevia Networksantevianetworks.comin 𝕏

Telecoms equipment vendor changing the economics of private 5G networks.

Avariwirelessavariwireless.comin 𝕏

Biomodalbiomodal.comin

Caringocaringo.comin 𝕏

DataCore provides software-defined data infrastructure and management solutions, including persistent storage for Kubernetes, hyperconverged infrastructure, ransomware protection, and active archiving across core, edge, and cloud environments.

Cloud ComputingData & InfrastructureEnterprise SoftwareAustin, US

Jonathan Ring(Executive Officer, Director)Paul Carpentier(Director)George Teixeira(Chairman of the Board, Co-founder)John Bocskor(Former DataCore Vice President, Product Development and Co-founder)Dave Zabrowski(Chief Executive Officer)Kevin Thimble(Chief Financial Officer)

Daliwirelessdaliwireless.comin 𝕏

Dust Identitydustidentity.comin

Gtxcelgtxcel.com

Berkeley, US

Peter Stilson(Executive Officer, Director)Becky Zehr(Executive Officer)

BoardDavid Fry(Director)Peter Flaherty(Director)Paul Baszucki(Director)William Cobert(Director)

High-capacity urban mass transitglydways.comin 𝕏

Glydways builds an on-demand public transit system using autonomous vehicles that operates on existing infrastructure, moving more passengers than rail while costing 90% less to build and operate.

AI & Machine LearningMobility & TransportationRoboticsBrisbane, US

Mark Seeger(Co-CEO, Founder)inZach Zeliff(Co-Founder, Chief Product Solutions)inBlake Barber(Co-CEO, CTO)inChris Riley(Executive Officer)Gokul Hemmady(Executive Officer)

BoardPaul Ferris(Director)

Icadmedicadmed.comin

Kateevakateeva.comin 𝕏

Lightningsitelightningsite.io

Long Walllwall.comin 𝕏

Morroweyewearmorroweyewear.comin

Myrtle.ai - companymyrtle.aiin 𝕏

Northsea Therapeuticsnorthseatherapeutics.com

Novadipnovadip.comin

Pakal Techpakal-tech.comin

Pakal Technologies

San Francisco, US

Benjamin Quinones(Executive Officer, Director)Richard Blanchard(Director)Jackie Yang(Director)TC Wu(Director)Eric Sullivan(Director)

Paradigmdxparadigmdx.comin 𝕏

Paragraf - companyparagraf.comin 𝕏Apr 2023

Graphene electronics company pioneering mass production of graphene-based devices.

Cambridgeshire

Simon Thomas(Chief Executive Officer of the issuer.)

Resolve Therapeuticsresolvetherapeutics.com

Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.

Sagence AIsagence-ai.comin

Sagence AI develops semiconductor technology based on analog in-memory compute methods to enable efficient AI computing for edge and data center applications.

AI & Machine LearningDeep TechHardwareSemiconductors

Vishal Sarin(Founder, President & CEO)

TigerConnecttigerconnect.comin

Trellis BioscienceJan 2026

BiotechRedwood City, US

Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)Geoff Dillon(Chief Business Officer)Elisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)

Trellisbiotrellisbio.comin

Ventyx Biosciencesventyxbio.com

San Diego, US

Mark S. Forman(Executive Officer)Matthew Moore(Executive Officer)John Nuss(Executive Officer)Jigar Choksey(Director)Martin Auster(Executive Officer)Christopher W. Krueger(Executive Officer)

Voragotechvoragotech.comin 𝕏

VORAGO Technologies designs radiation-hardened and radiation-tolerant Arm Cortex-based microcontrollers and microprocessors using its HARDSIL process technology to protect chips in extreme environments.

Defense TechSemiconductorsSpace Tech

VUV Analyticsvuvanalytics.comin 𝕏

Cedar Park, US

Joseph H. Timko(Director)Kirk Patterson(Executive Officer)Clark Jernigan(Executive Officer, Director)Brian R. Smith(Director)

BoardEric Engineer(Director)

zeotapzeotap.comin

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

The $9M push to crack prosthetic joint infections - Becker’s Spine Review

Trellis Bioscience · beckersspine.com · Jul 20, 2026

Palm Beach County commissioners pause automated transit proposal connecting airport to downtown

High-capacity urban mass transit · wptv.com · Jul 8, 2026

Frequently asked questions

What stage does New Science Ventures invest at?: New Science Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is New Science Ventures's typical check size?: New Science Ventures typically writes checks of $2M – $8M.
What sectors does New Science Ventures focus on?: New Science Ventures focuses on AI & Machine Learning, Biotech, Data & Infrastructure, Deep Tech, Digital Health, Enterprise Software, Healthtech, Medical Devices, Mobility & Transportation, New Materials, Semiconductors, Space Tech.
Where is New Science Ventures located?: New Science Ventures is headquartered in Greenwich, US.
Does New Science Ventures lead rounds?: Yes, New Science Ventures leads investment rounds.

Images

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a deep tech investor backing companies across the themes of Intelligence, Human potential, and the Planet.

$50K – $12.7M

Quad Ventures

Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.

Cowin Capital Group

Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.

$1.4M – $50M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.

$100K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M